TADALAFIL and COUGH

Overview

COUGH is the #10 most commonly reported adverse reaction for TADALAFIL, manufactured by United Therapeutics Corporation. There are 4,198 FDA adverse event reports linking TADALAFIL to COUGH. This represents approximately 2.0% of all 207,750 adverse event reports for this drug.

TADALAFIL has an overall safety score of 85 out of 100. Patients taking TADALAFIL who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COUGH is a less commonly reported adverse event for TADALAFIL, but still significant enough to appear in the safety profile.

Other Side Effects of TADALAFIL

In addition to cough, the following adverse reactions have been reported for TADALAFIL:

• DYSPNOEA — 11,665 reports
• HEADACHE — 10,690 reports
• DIARRHOEA — 7,799 reports
• NAUSEA — 6,498 reports
• DEATH — 5,897 reports
• FATIGUE — 5,836 reports
• DRUG INEFFECTIVE — 5,433 reports
• DIZZINESS — 5,176 reports
• PNEUMONIA — 4,224 reports
• MALAISE — 3,722 reports

Other Drugs Associated with COUGH

The following drugs have also been linked to cough in FDA adverse event reports:

Does TADALAFIL cause COUGH?

COUGH has been reported as an adverse event in 4,198 FDA reports for TADALAFIL. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COUGH with TADALAFIL?

COUGH accounts for approximately 2.0% of all adverse event reports for TADALAFIL, making it a notable side effect.

What should I do if I experience COUGH while taking TADALAFIL?

If you experience cough while taking TADALAFIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages